Silence Therapeutics reported $118.66M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
AstraZeneca USD 29.61B 890M Mar/2026
Autolus Therapeutics Ltd USD 368.84M 67.08M Mar/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Novartis USD 26.61B 3.85B Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Silence Therapeutics USD 118.66M 14.97M Dec/2025